Laddar...
Naproxen in rheumatoid arthritis. Extended trial.
121 patients with active rheumatoid arthritis, 91 of whom had proved intolerant of other nonsteroidal anti-inflammatory agents, were treated for a mean of 10 months with naproxen. A dosage of 250 mg twice daily produced sustained improvement in most of the standard clinical measurements. 28 patients...
Sparad:
| I publikationen: | Ann Rheum Dis |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BMJ Publishing Group
1976
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1006592/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/795386/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.35.6.498 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|